2015
DOI: 10.1007/s40556-015-0043-1
|View full text |Cite
|
Sign up to set email alerts
|

FISH is not Suitable as a Standalone Test for Detecting Fetal Chromosomal Abnormalities

Abstract: Karyotyping and fluorescence in situ hybridization (FISH) detect fetal chromosome abnormalities. The choice between karyotyping and FISH is still debatable. In a developing country, parents face an emotional and economic constraint of a prenatal test. Therefore, the results of karyotyping and FISH were analyzed to determine the percentage of clinically abnormal fetuses which would be missed by using standalone FISH. Amniotic fluid samples from 9033 high-risk pregnancies were subjected to karyotyping and FISH f… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
8
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 16 publications
0
8
0
Order By: Relevance
“…24 While FISH has been a crucial technique used in aneuploidy detection, many DNA-based technologies continue to outperform this technique due to the low resolution, limits on how many chromosomes can be analyzed, and the accuracy of the technique compared with others. 25…”
Section: Molecular-based Approaches For Detecting and Studying Aneuploidymentioning
confidence: 99%
“…24 While FISH has been a crucial technique used in aneuploidy detection, many DNA-based technologies continue to outperform this technique due to the low resolution, limits on how many chromosomes can be analyzed, and the accuracy of the technique compared with others. 25…”
Section: Molecular-based Approaches For Detecting and Studying Aneuploidymentioning
confidence: 99%
“…For example, the European LeukemiaNet (ELN) recommendations for diagnosis and management of acute myeloid leukemia (AML) state conventional cytogenetic analysis remains mandatory in the evaluation of suspected AML, and these guidelines provide risk stratification recommendations based on the results of cytogenetic studies ( 5 ). However, cytogenetic analysis has considerable limitations as these studies are more costly, require fresh viable cells for culturing, need to be manually performed by an expert, and have a turnaround time of approximately two weeks for results ( 6 ). Therefore, there has been growing interest in alternative and less invasive methods to determine chromosomal variations for patients with hematologic neoplasms.…”
Section: Introductionmentioning
confidence: 99%
“…One widely accepted method as an adjunct to cytogenetic analysis is fluorescence in situ hybridization (FISH) studies, which comparatively have a shorter turnaround time to results of approximately 2 days, are more cost effective, can be prepared in formalin-fixed paraffin-embedded (FFPE) samples, and eliminates the need for tissue cultures ( 6 , 7 ). However, FISH studies can only test for predetermined chromosomal abnormalities one at a time and are unable to identify other non-targeted chromosomal variations ( 6 ). Recent advances in high-throughput genomic technologies have allowed for broader evaluation of chromosomal abnormalities using arrays.…”
Section: Introductionmentioning
confidence: 99%
“…3,5 FISH is a targeted approach and has some limitations. 6 Sometimes multiple attempts of FISH with various centromere enumerating probes or whole chromosome paint probes may be required, sequentially, even then the gene content remains undefined. The newer approach of Chromosome Microarray Analysis (CMA) offers identification of the copy number variations (CNVs) at the whole genome level along with defined breakpoints and the gene content of the involved duplication forming the SMC.…”
Section: Introductionmentioning
confidence: 99%